O	O	0	3	The	The	B-NP	DT	O	2	NMOD	O
O	O	4	8	role	role	I-NP	NN	O	16	NMOD	O
O	O	9	11	of	of	B-PP	IN	O	2	NMOD	O
O	O	12	15	Rel	Rel	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	15	16	/	/	B-NP	SYM	I-protein	10	NMOD	I-protein
T1	B-Entity	16	18	NF	NF	I-NP	NN	I-protein	10	NMOD	I-protein
T1	I-Entity	18	19	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T1	I-Entity	19	24	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T1	I-Entity	25	26	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	27	35	proteins	protein	I-NP	NNS	I-protein	3	PMOD	I-protein
O	O	36	38	in	in	B-PP	IN	O	2	NMOD	O
O	O	39	44	viral	viral	B-NP	JJ	O	13	NMOD	O
O	O	45	56	oncogenesis	oncogenesis	I-NP	NN	O	11	PMOD	O
O	O	57	60	and	and	O	CC	O	16	NMOD	O
O	O	61	64	the	the	B-NP	DT	O	16	NMOD	O
O	O	65	75	regulation	regulation	I-NP	NN	O	0	ROOT	O
O	O	76	78	of	of	B-PP	IN	O	16	NMOD	O
O	O	79	84	viral	viral	B-NP	JJ	O	19	NMOD	O
O	O	85	98	transcription	transcription	I-NP	NN	O	17	PMOD	O
O	O	98	99	.	.	O	.	O	16	P	O

T2	B-Entity	101	104	Rel	Rel	B-NP	NN	B-protein	6	NMOD	B-protein
T2	I-Entity	104	105	/	/	I-NP	SYM	O	6	NMOD	O
T2	I-Entity	105	107	NF	NF	I-NP	NN	B-protein	6	NMOD	B-protein
T2	I-Entity	107	108	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T2	I-Entity	108	113	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T2	I-Entity	114	115	B	B	I-NP	NN	I-protein	7	SUB	I-protein
O	O	116	118	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	119	120	a	a	B-NP	DT	O	11	NMOD	O
T3	B-Entity	121	131	ubiquitous	ubiquitous	I-NP	JJ	B-protein	11	NMOD	B-protein
T3	I-Entity	132	145	transcription	transcription	I-NP	NN	I-protein	11	NMOD	I-protein
T3	I-Entity	146	152	factor	factor	I-NP	NN	I-protein	7	PRD	I-protein
O	O	153	157	that	that	B-NP	WDT	O	11	NMOD	O
O	O	158	166	consists	consist	B-VP	VBZ	O	12	SBAR	O
O	O	167	169	of	of	B-PP	IN	O	13	VMOD	O
O	O	170	178	multiple	multiple	B-NP	JJ	B-protein	17	NMOD	B-protein
O	O	179	190	polypeptide	polypeptide	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	191	199	subunits	subunit	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	199	200	,	,	O	,	O	7	P	O
O	O	201	204	and	and	O	CC	O	7	VMOD	O
O	O	205	207	is	be	B-VP	VBZ	O	7	VMOD	O
O	O	208	215	subject	subject	B-ADJP	JJ	O	20	PRD	O
O	O	216	218	to	to	B-PP	TO	O	21	AMOD	O
O	O	219	226	complex	complex	B-NP	JJ	O	25	NMOD	O
O	O	227	237	regulatory	regulatory	I-NP	JJ	O	25	NMOD	O
O	O	238	248	mechanisms	mechanism	I-NP	NNS	O	22	PMOD	O
O	O	249	253	that	that	B-NP	WDT	O	25	NMOD	O
O	O	254	261	involve	involve	B-VP	VBP	O	26	SBAR	O
O	O	262	269	protein	protein	B-NP	NN	O	31	NMOD	O
O	O	269	270	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	270	277	protein	protein	I-NP	NN	O	31	NMOD	O
O	O	278	290	interactions	interaction	I-NP	NNS	O	42	NMOD	O
O	O	290	291	,	,	O	,	O	42	P	O
O	O	292	307	phosphorylation	phosphorylation	B-NP	NN	O	42	NMOD	O
O	O	307	308	,	,	O	,	O	42	P	O
O	O	309	323	ubiquitination	ubiquitination	B-NP	NN	O	42	NMOD	O
O	O	323	324	,	,	O	,	O	42	P	O
O	O	325	336	proteolytic	proteolytic	B-NP	JJ	O	38	NMOD	O
O	O	337	348	degradation	degradation	I-NP	NN	O	42	NMOD	O
O	O	348	349	,	,	O	,	O	42	P	O
O	O	350	353	and	and	O	CC	O	42	NMOD	O
O	O	354	371	nucleocytoplasmic	nucleocytoplasmic	B-NP	JJ	O	42	NMOD	O
O	O	372	385	translocation	translocation	I-NP	NN	O	27	OBJ	O
O	O	385	386	.	.	O	.	O	7	P	O

O	O	387	390	The	The	B-NP	DT	O	3	NMOD	O
O	O	391	404	sophisticated	sophisticated	I-NP	JJ	O	3	NMOD	O
O	O	405	412	control	control	I-NP	NN	O	12	SUB	O
O	O	413	415	of	of	B-PP	IN	O	3	NMOD	O
T4	B-Entity	416	419	Rel	Rel	B-NP	NN	B-protein	11	NMOD	B-protein
T4	I-Entity	419	420	/	/	B-NP	SYM	O	11	NMOD	O
T4	I-Entity	420	422	NF	NF	I-NP	NN	B-protein	11	NMOD	B-protein
T4	I-Entity	422	423	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T4	I-Entity	423	428	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T4	I-Entity	429	430	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	431	439	activity	activity	I-NP	NN	O	4	PMOD	O
O	O	440	442	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	443	446	not	not	O	RB	O	12	VMOD	O
O	O	447	457	surprising	surprising	B-ADJP	JJ	O	12	PRD	O
O	O	458	463	since	since	B-SBAR	IN	O	12	VMOD	O
O	O	464	468	this	this	B-NP	DT	O	18	NMOD	O
O	O	469	482	transcription	transcription	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	483	489	factor	factor	I-NP	NN	I-protein	19	SUB	I-protein
O	O	490	492	is	be	B-VP	VBZ	O	15	SBAR	O
O	O	493	501	involved	involve	I-VP	VBN	O	19	VC	O
O	O	502	504	in	in	B-PP	IN	O	20	VMOD	O
O	O	505	506	a	a	B-NP	DT	O	24	NMOD	O
O	O	507	511	wide	wide	I-NP	JJ	O	24	NMOD	O
O	O	512	517	array	array	I-NP	NN	O	21	PMOD	O
O	O	518	520	of	of	B-PP	IN	O	24	NMOD	O
O	O	521	529	cellular	cellular	B-NP	JJ	O	27	NMOD	O
O	O	530	539	responses	response	I-NP	NNS	O	25	PMOD	O
O	O	540	542	to	to	B-PP	TO	O	27	NMOD	O
O	O	543	556	extracellular	extracellular	B-NP	JJ	O	30	NMOD	O
O	O	557	561	cues	cue	I-NP	NNS	O	28	PMOD	O
O	O	561	562	,	,	O	,	O	24	P	O
O	O	563	573	associated	associate	B-VP	VBN	O	24	NMOD	O
O	O	574	578	with	with	B-PP	IN	O	32	VMOD	O
O	O	579	585	growth	growth	B-NP	NN	O	42	NMOD	O
O	O	585	586	,	,	O	,	O	42	P	O
O	O	587	598	development	development	B-NP	NN	O	42	NMOD	O
O	O	598	599	,	,	O	,	O	42	P	O
O	O	600	609	apoptosis	apoptosis	B-NP	NN	O	42	NMOD	O
O	O	609	610	,	,	O	,	O	42	P	O
O	O	611	614	and	and	O	CC	O	42	NMOD	O
O	O	615	623	pathogen	pathogen	B-NP	NN	O	42	NMOD	O
O	O	624	632	invasion	invasion	I-NP	NN	O	33	PMOD	O
O	O	632	633	.	.	O	.	O	12	P	O

O	O	634	638	Thus	Thus	B-ADVP	RB	O	4	VMOD	O
O	O	638	639	,	,	O	,	O	4	P	O
O	O	640	642	it	it	B-NP	PRP	O	4	SUB	O
O	O	643	645	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	646	649	not	not	O	RB	O	4	VMOD	O
O	O	650	660	unexpected	unexpected	B-ADJP	JJ	O	4	PRD	O
O	O	661	665	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	666	670	this	this	B-NP	DT	O	12	NMOD	O
O	O	671	680	versatile	versatile	I-NP	JJ	O	11	AMOD	O
O	O	681	689	cellular	cellular	I-NP	JJ	O	11	AMOD	O
O	O	690	701	homeostatic	homeostatic	I-NP	JJ	O	12	NMOD	O
O	O	702	708	switch	switch	I-NP	NN	O	13	SUB	O
O	O	709	714	would	would	B-VP	MD	O	7	SBAR	O
O	O	715	717	be	be	I-VP	VB	O	13	VC	O
O	O	718	726	affected	affect	I-VP	VBN	O	14	VC	O
O	O	727	729	by	by	B-PP	IN	O	15	VMOD	O
O	O	730	731	a	a	B-NP	DT	O	18	NMOD	O
O	O	732	739	variety	variety	I-NP	NN	O	16	PMOD	O
O	O	740	742	of	of	B-PP	IN	O	18	NMOD	O
O	O	743	748	viral	viral	B-NP	JJ	O	21	NMOD	O
O	O	749	758	pathogens	pathogen	I-NP	NNS	O	19	PMOD	O
O	O	758	759	,	,	O	,	O	4	P	O
O	O	760	765	which	which	B-NP	WDT	O	4	VMOD	O
O	O	766	770	have	have	B-VP	VBP	O	23	SBAR	O
O	O	771	778	evolved	evolve	I-VP	VBN	O	24	VC	O
O	O	779	789	mechanisms	mechanism	B-NP	NNS	O	25	OBJ	O
O	O	790	792	to	to	B-VP	TO	O	28	VMOD	O
O	O	793	800	utilize	utilize	I-VP	VB	O	26	NMOD	O
O	O	801	808	various	various	B-NP	JJ	O	30	NMOD	O
O	O	809	816	aspects	aspect	I-NP	NNS	O	28	OBJ	O
O	O	817	819	of	of	B-PP	IN	O	30	NMOD	O
T5	B-Entity	820	823	Rel	Rel	B-NP	NN	B-protein	38	NMOD	B-protein
T5	I-Entity	823	824	/	/	B-NP	SYM	O	38	NMOD	O
T5	I-Entity	824	826	NF	NF	I-NP	NN	B-protein	38	NMOD	B-protein
T5	I-Entity	826	827	-	-	B-NP	HYPH	I-protein	38	NMOD	I-protein
T5	I-Entity	827	832	kappa	kappa	I-NP	NN	I-protein	38	NMOD	I-protein
T5	I-Entity	833	834	B	B	I-NP	NN	I-protein	38	NMOD	I-protein
O	O	835	843	activity	activity	I-NP	NN	O	31	PMOD	O
O	O	844	846	to	to	B-VP	TO	O	40	VMOD	O
O	O	847	857	facilitate	facilitate	I-VP	VB	O	24	VMOD	O
O	O	858	863	their	their	B-NP	PRP$	O	42	NMOD	O
O	O	864	875	replication	replication	I-NP	NN	O	48	NMOD	O
O	O	875	876	,	,	O	,	O	48	P	O
O	O	877	881	cell	cell	B-NP	NN	O	45	NMOD	O
O	O	882	890	survival	survival	I-NP	NN	O	48	NMOD	O
O	O	891	894	and	and	O	CC	O	48	NMOD	O
O	O	895	903	possibly	possibly	B-ADVP	RB	O	48	NMOD	O
O	O	904	911	evasion	evasion	B-NP	NN	O	40	OBJ	O
O	O	912	914	of	of	B-PP	IN	O	48	NMOD	O
O	O	915	921	immune	immune	B-NP	JJ	O	51	NMOD	O
O	O	922	931	responses	response	I-NP	NNS	O	49	PMOD	O
O	O	931	932	.	.	O	.	O	4	P	O

O	O	933	937	This	This	B-NP	DT	O	2	NMOD	O
O	O	938	944	review	review	I-NP	NN	O	3	SUB	O
O	O	945	949	will	will	B-VP	MD	O	0	ROOT	O
O	O	950	955	cover	cover	I-VP	VB	O	3	VC	O
O	O	956	959	the	the	B-NP	DT	O	7	NMOD	O
O	O	960	969	molecular	molecular	I-NP	JJ	O	7	NMOD	O
O	O	970	980	mechanisms	mechanism	I-NP	NNS	O	4	OBJ	O
O	O	981	985	that	that	B-NP	WDT	O	7	NMOD	O
O	O	986	989	are	be	B-VP	VBP	O	8	SBAR	O
O	O	990	998	utilized	utilize	I-VP	VBN	O	9	VC	O
O	O	999	1001	by	by	B-PP	IN	O	10	VMOD	O
O	O	1002	1011	mammalian	mammalian	B-NP	JJ	O	14	NMOD	O
O	O	1012	1021	oncogenic	oncogenic	I-NP	JJ	O	14	NMOD	O
O	O	1022	1029	viruses	virus	I-NP	NNS	O	11	PMOD	O
O	O	1030	1032	to	to	B-VP	TO	O	16	VMOD	O
O	O	1033	1039	affect	affect	I-VP	VB	O	9	VMOD	O
O	O	1040	1043	the	the	B-NP	DT	O	18	NMOD	O
O	O	1044	1052	activity	activity	I-NP	NN	O	30	NMOD	O
O	O	1053	1055	of	of	B-PP	IN	O	18	NMOD	O
T6	B-Entity	1056	1059	Rel	Rel	B-NP	NN	B-protein	27	NMOD	B-protein
T6	I-Entity	1059	1060	/	/	B-NP	SYM	O	27	P	O
T6	I-Entity	1060	1062	NF	NF	I-NP	NN	B-protein	25	NMOD	B-protein
T6	I-Entity	1062	1063	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T6	I-Entity	1063	1068	kappa	kappa	I-NP	NN	I-protein	25	NMOD	I-protein
T6	I-Entity	1069	1070	B	B	I-NP	NN	I-protein	27	NMOD	I-protein
T6	I-Entity	1071	1084	transcription	transcription	I-NP	NN	B-protein	27	NMOD	B-protein
T6	I-Entity	1085	1092	factors	factor	I-NP	NNS	I-protein	19	PMOD	I-protein
O	O	1093	1096	and	and	O	CC	O	30	NMOD	O
O	O	1097	1100	the	the	B-NP	DT	O	30	NMOD	O
O	O	1101	1105	role	role	I-NP	NN	O	16	OBJ	O
O	O	1106	1108	of	of	B-PP	IN	O	30	NMOD	O
T7	B-Entity	1109	1112	Rel	Rel	B-NP	NN	B-protein	37	NMOD	B-protein
T7	I-Entity	1112	1113	/	/	B-NP	SYM	O	37	P	O
T7	I-Entity	1113	1115	NF	NF	I-NP	NN	B-protein	37	NMOD	B-protein
T7	I-Entity	1115	1116	-	-	B-NP	HYPH	I-protein	37	NMOD	I-protein
T7	I-Entity	1116	1121	kappa	kappa	I-NP	NN	I-protein	37	NMOD	I-protein
T7	I-Entity	1122	1123	B	B	I-NP	NN	I-protein	31	PMOD	I-protein
O	O	1124	1126	in	in	B-PP	IN	O	30	NMOD	O
O	O	1127	1130	the	the	B-NP	DT	O	40	NMOD	O
O	O	1131	1141	regulation	regulation	I-NP	NN	O	38	PMOD	O
O	O	1142	1144	of	of	B-PP	IN	O	40	NMOD	O
T8	B-Entity	1145	1150	viral	viral	B-NP	JJ	O	44	NMOD	O
T8	I-Entity	1151	1155	gene	gene	I-NP	NN	O	44	NMOD	O
O	O	1156	1166	expression	expression	I-NP	NN	O	46	NMOD	O
O	O	1167	1170	and	and	O	CC	O	46	NMOD	O
O	O	1171	1182	replication	replication	B-NP	NN	O	41	PMOD	O
O	O	1182	1183	.	.	O	.	O	3	P	O
